trending Market Intelligence /marketintelligence/en/news-insights/trending/F9CHycAoVldGHzk2scJ1Gg2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Innovus Pharmaceuticals secures $3.2M investment


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Innovus Pharmaceuticals secures $3.2M investment

San Diego-based over-the-counter consumer goods and specialty pharmaceutical company Innovus Pharmaceuticals Inc. said it secured a $3.2 million investment from a healthcare-focused institutional investor.

The company will sell 45,306,347 shares to the undisclosed investor, complete with two separate warrants to buy an equal number of shares in the future, for 7 cents each.

The transaction is expected to close by Jan. 3, 2019, with H.C. Wainwright & Co. acting as the exclusive placement agent.

Innovus Pharmaceuticals intends to use the net proceeds for working capital and general corporate purposes.